Postmarketing conditions of respiratory depression, together with fatalities, have been claimed with use of promethazine in pediatric sufferers considerably less than 2 years of age. An array of excess weight-centered doses of promethazine have resulted in respiratory melancholy in these clients.Drugwatch.com has furnished responsible, reliable spe